Free Newsletter
Adcock Ingram gives up on Cipla Medpro
Free newsletter via e-mail
Tools
Adcock Ingram abandoned a takeover of Cipla Medpro South Africa after discovering that India's Cipla may cancel a supply agreement with its smaller rival, casting doubt over the merits of the bid. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: